title: [Lung Excision for Clinical Stage I Lung Cancer].
abstract: A strategy of indicating lung excision for high risk patients is discussed based on reviewing of treatments for clinical stage I lung cancer. According to clinical studies of lung excision or stereotactic body radiation therapy both results may be similar, while a multicenter randomized prospective study is on-going. Since the result of lung excision may be revealed to depend on tumor size, tumor location in the lung, distance from surgical margin to tumor, tumor size-margin distance ratio and margin cytology results, a prospective study is recommended, which will be able to assessed clinical implications of such factors to extract patients having good prognoses.
authors: Department of Thoracic Surgery, Hoshigaoka Medical Center, Hirakata, Japan.
authors: Noriyoshi
authors: N
authors: Sawabata
authors: Noriyuki
authors: N
authors: Matsutani
authors: Akikazu
authors: A
authors: Kawase
authors: Nobumasa
authors: N
authors: Takahashi
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000532:radiotherapy / Q000601:surgery*; D009367:Neoplasm Staging; D011013:Pneumonectomy; D016896:Treatment Outcome